Hubungan Psikopatologi dengan Kualitas Hidup pada Pasien Psoriasis

Authors

  • Andray Hadi Texanto Department Psikiatri, Fakultas Kedokteran Universitas Sebelas Maret Surakarta, Indonesia
  • Debree Septiawan Department Psikiatri, Fakultas Kedokteran Universitas Sebelas Maret Surakarta, Indonesia
  • Rohmaningtya Department Psikiatri, Fakultas Kedokteran Universitas Sebelas Maret Surakarta, Indonesia
  • Wijaya Kusuma Department Psikiatri, Fakultas Kedokteran Universitas Sebelas Maret Surakarta, Indonesia

DOI:

https://doi.org/10.32807/bnj.v7i2.1895

Keywords:

Psychopathology; Quality of Life; Psoriasis

Abstract

Psoriasis is an autoimmune disease in the form of chronic inflammation that attacks the skin. Individuals with psoriasis increase psychopathological comorbidities compared to individuals without psoriasis, namely symptoms of depression and anxiety with a prevalence ranging from 20-50%, schizophrenia 2.82% and suicidal ideation 12.7% where most will experience a decrease in quality of life and psychosocial disorders. This study aims to determine the relationship of psychopathology with quality of life in psoriasis patients. Using a descriptive analytical method, where a total of 35 respondents of psoriasis patients at the dermatology and venereal disease outpatient clinic of Dr. Moewardi Surakarta Hospital were involved in this study. Data were collected by filling out a questionnaire consisting of: demographic data, psychopathology measured using the Symptom Check List-90 (SCL-90) and quality of life measured using the Dermatology Life Quality Index (DLQI). Data analysis through correlational analysis with a cross-sectional approach using SPSS 25. The results of this study showed that psoriasis patients who experienced psychopathology were 66.7% and those who did not experience psychopathology were 34.3%. A bivariate test between psychopathology and quality of life using the Mann-Whitney test showed p=0.00, indicating a significant relationship between psychopathology and quality of life in psoriasis patients. Therefore, it can be concluded that there is a significant relationship between psychopathology and quality of life in psoriasis patients.

References

Afifi, Ladan., Danesh, Melissa J., Lee, Kristina M., Beroukhim, Kevin., Farahnik, Benjamin., Ahn, Richard S., et al. (2018). Dietary behaviors in psoriasis: patient-reported outcomes from a U.S. National survey. Adis Journals. Figure. https://doi.org/10.6084/m9.figshare.6194909.v1.

Adesanya, E. I., Matthewman, J., Schonmann, Y., Hayes, J. F., Henderson, A., Mathur, R., Mulick, A. R., Smith, C. H., Langan, M. S., & Mansfield, K. E. (2023). Factors associated with depression, anxiety and severe mental illness among adults with atopic eczema or psoriasis: A systematic review and meta-analysis. In British Journal of Dermatology (Vol. 188, Issue 4, pp. 460–470. Oxford University Press. https://doi.org/10.1093/bjd/ljac132.

Armstrong, A.W & Read C. (2020). Pathophysiology, clinical presentation, and treatment of psoriasis: A review. JAMA. 323:1945-60.

Augustin, M., and Radtke, M.A., (2014). Quality of life in psoriasis patients, 14(4), pp. 559-568.

Bakar, R.S., Jaapar, S.Z.S., Azmi, A.F. and Aun, Y.C. (2021) Depression and Anxiety among Patients with Psoriasis: A Correlation with Quality of Life and Associated Factors. Journal of Taibah University Medical Sciences, 16, 491-496. https://doi.org/10.1016/j.jtumed.2021.02.008

Barrea, L., Nappi, F., Di Somma, C., Savanelli, M.C., Falco, A., Balato, A., Savastano, S. (2016). Environmental risk factors in psoriasis: the point of view of the nutritionist. Int J environmental research and public health. 13(7): 743.

Blauvelt, A., Papp, K. A., Griffiths, C. E., Randazzo, B., Wasfi, Y., Shen, Y. K., ... & Kimball, A. B. (2017). Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: results from the phase III, double-blinded, placebo-and active comparator–controlled VOYAGE 1 trial. Journal of the American Academy of Dermatology, 76(3), 405-417.

Brenaut, E., Horreau, C., Pouplard, C., Barnetche, T., Paul, C., Richard, M.A., Cribier, B. (2013). Alcohol consumption and psoriasis: a systematic literature review. J European Academy Dermatology and Venereology. 27: 30-5.

Brezinski, E.A., Dhillon, J.S., and Armstrong, A.W., (2015). Economic Burden of Psoriasis in the United States: A Systematic Review, JAMA Dermatology, 151(6), pp. 651-658.

Brown G, Wang E, Huynh M, Wehner M, Matro R, Linos E, Haemel A. 2017. Tumor necrosis factor-? inhibitor-induced psoriasis: systematic review of clinical features, histopathological findings, and management experience. J American Academy of Dermatology. 76(2): 334-41.

Burden, A.D., and Kirby, B., (2016). Rook's Textbook of Dermatology, Rook's Textbook of Dermatology [Preprint].

Carrascosa, J. M., Rocamora, V., Fernandez-Torres, R. M., Jimenez-Puya, R., Moreno, J. C., Coll-Puigserver, N., & Fonseca, E. (2014). Obesity and Psoriasis: Inflammatory Nature of Obesity, Relationship Between Psoriasis and Obesity, and Therapeutic Implications. Actas Dermo-Sifiliográficas (English Edition), 105(1), 31–44. https://doi.org/10.1016/j.adengl.2012.08.024.

Chai, Q., Teeple, A., Wu, B., Muser, E. (2019). Prevalence and economic burden of comorbid anxiety and depression among patients with moderate-to-severe psoriasis. J medical economics. 22(12): 1290-7.

Chan, B., Hales, B., Shear, N., Ho, V., Lynde, C., Poulin, Y., & Mittmann, N. (2009). Work-related lost productivity and its economic impact on Canadian patients with moderate to severe psoriasis. Journal of Cutaneous Medicine and Surgery, 13(4), 192–197. https://doi.org/10.2310/7750.2009.08068.

Chiriac, A., Podoleanu, C., & Azoicai, D. (2017). Clinical and Epidemiological Factors Predicting the Severity of Psoriasis. In An Interdisciplinary Approach to Psoriasis. InTech. https://doi.org/10.5772/intechopen.68728.

Chu, M., Shen, S., Zhu, Z., Li, Z., Bai, Y., Ma, J., Hao, J., Wang, L., Fu, M., Dang, E., Wang, G. (2023). Association of psoriasis with depression, anxiety, and suicidality: A bidirectional two-sample Mendelian randomization study [published online ahead of print, Sep 12]. J Dermatol. 2023;10.1111/1346-8138.16941. doi:10.1111/1346-8138.16941.

Colombo, D., & Perego, R. (2013). Quality of Life in Psoriasis. In Psoriasis - Types, Causes and Medication. InTech. https://doi.org/10.5772/53998

Dalgard, F.J., Gieler, U., Tomas-Aragones, L., Lien, L., Poot, F., Jemec, G.B., Evers, A.W. (2015). The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 135(4): 984-91.

Egeberg, A., Thyssen, J.P., Wu, J.J., Skov, L..(2019). Risk of first-time and recurrent depression in patients with psoriasis: a population-based cohort study. Br J Dermatol ;180(1):116-121. doi:10.1111/bjd.17208.

Farkas, A., and Kemeny, L., 2010, The alcohol metabolite acetaldehyde and psoriasis:another trigger factor?, Clinical and experimental dermatology, 35(8), pp. 923-925.

Ferreira, B.I., Abreu, J.L., Reis, J.P., Figueiredo, A.M.(2016). Psoriasis and Associated Psychiatric Disorders: A Systematic Review on Etiopathogenesis and Clinical Correlation. J Clin Aesthet Dermatol; 9(6):36-43.

Fernandez?Peñas, P., Jones?Caballero, M., Espallardo, O., & García?Díez, A. (2012). Comparison of skindex?29, dermatology life quality index,

Finlay, A. Y., & Khan, G. K. (1994). Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. In Clinical and Experimental Dermatology (Vol. 19).

Gelfand JM, Dommasch ED, Shin DB, Azfar RS, Kurd SK, Wang X, & et al. (2009). The risk of stroke in patients with psoriasis. J Invest Dermatol, 129, 2411–2418.

Griffiths, C.E.M., Armstrong, A.W., Gudjonsson, J.E., Barker, J.N.W.N. (2021) Psoriasis. Lancet.;397(10281):1301-1315. doi:10.1016/S0140-6736(20)32549-6.

Gudjonson JE, Elder JT. 2019. Psoriasis. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editor. Fitzpatrick's Dermatology in General Medicine. 8th Ed. New york: Mcgraw Hill Companies Inc.: 197 – 231.

Harden, J.L., Krueger, J.G., Bowcock, A.M. (2015). The immunogenetics of psoriasis: a comprehensive review. J autoimmunity. 64: 66-73.

Hawro, T., A. Zalewska., Hawro, M., Kaszuba, A., Królikowska, M., Maurer, M. (2015). Impact of psoriasis severity on family income and quality of life, Journal of the European Academy of Dermatology and Venereology, 29(3), pp.438-443.

Hedemann, T.L., Liu, X., Kang, C.N., Husain, M.I. (2022) Associations between psoriasis and mental illness: an update for clinicians. Gen Hosp Psychiatry. 2022;75:30-37. doi:10.1016/j.genhosppsych.2022.01.006.

Hernandez, M., Simms-Cendan, J., Zendell, K. (2015). Guttate psoriasis following streptococcal vulvovaginitis in a five-year-old girl. J Pediatric and Adolescent Gynecology. 28(5): e127-9.

Hrehorow, E., Salomon, J., Matusiak, L., Reich, A., Szepietowski, J.C. (2012) Patients with psoriasis feel stigmatized, Acta DermatoVenereologica, 92(1), pp. 67-72.

Jing, D., Xiao, H., Shen, M., Chen, X., Han, X., Kuang, Y., Zhu, W., Xiao, Y.(2021) Association of Psoriasis With Anxiety and Depression: A Case-Control Study in Chinese Patients. Front Med (Lausanne). Dec 24;8:771645. doi: 10.3389/fmed.2021.771645. PMID: 35004741; PMCID: PMC8738085.

Jorgenson, J. (2017). Symptom Checklist-90-Revised. Encyclopedia of Personality and Individual Differences, 2000, 1–4. https://doi.org/10.1007/978-3-319-28099-8_951-1.

Chiriac, A., Podoleanu, C., & Azoicai, D. (2017). Clinical and Epidemiological Factors Predicting the Severity of Psoriasis. In An Interdisciplinary Approach to Psoriasis. InTech. https://doi.org/10.5772/intechopen.68728.

Krisnarto, E., Novitasari, A., Aulirahma, D.M. (2016). Faktor Prediktor Kualitas Hidup Pasien Psoriasis: Studi Cross Sectional. Jurnal Kedokteran Muhammadiyah. Universitas Muhamadiah Semarang. Vol 5, N0 1. ISSN: 2301-8585. https://jurnal.unimus.ac.id/index.php/kedokteran/article/view/2584.

Lane, H., & Walker, M. (2023). The Impact of Temperature, Humidity, and Sunshine on Internet Search Volumes Related to Psoriasis. JMIR Dermatology, 6(1). https://doi.org/10.2196/49901

Langenbruch, A., Radtke, M. A., Gutknecht, M., & Augustin, M. (2019). Does the Dermatology Life Quality Index (DLQI) underestimate the disease?specific burden of psoriasis patients?. Journal of the European Academy of Dermatology and Venereology, 33(1), 123-127.

Lee, E. J., Do Han, K., Han, J. H., & Lee, J. H. (2017). Smoking and risk of psoriasis: a nationwide cohort study. Journal of the American Academy of Dermatology, 77(3), 573-575.

Levy, A.R, Davie, A.M., Brazier, N.C., Jivraj, F., Albrecht, L.E., Gratton, D., Lynde, C.W. (2012) Economic burden of moderate to severe plaque psoriasis in Canada, International Journal of Dermatology, 51(12), pp. 1432-1440

Liauw, F., Umar, F. A., Hendrianto, F., Idrus, H., Pinontoan, H. S., Widyahening, I. S., & Adjie, J. M. S. (2007). Skoring Psikopatologi dan Faktor yang Berhubungan pada Perempuan Usia Perimenopause.

Maheswari, A., & Dutta, B. (2021). Correlation of hypocalcaemia with severity and type of psoriasis: A cross-sectional study. IP Indian Journal of Clinical and Experimental Dermatology, 7(2), 164–168. https://doi.org/10.18231/j.ijced.2021.031

Malhi, G. S., & Mann, J. J. (2018). Depression. In The Lancet (Vol. 392, Issue 10161, pp. 2299–2312). Lancet Publishing Group. https://doi.org/10.1016/S0140-6736(18)31948-2.

Michalek, I. M., Loring, B., & John, S. M. (2017). A systematic review of worldwide epidemiology of psoriasis. Journal of the European Academy of Dermatology and Venereology, 31(2), 205–212. https://doi.org/10.1111/jdv.13854.

Milena, W & McFarlane, Oliwia & Betyna-Bia?ek, Monika. (2023). Impact of Mental State on the Severity of Psoriasis Symptoms: A Study on Patient's Emotional Well-Being. Medical Science Monitor. 29. 10.12659/MSM.941636.

Moncef, M & el Harch, Ibtissam & Chakri, Imad & Benmaamar, Soumaya & Bay, Hanane & Otmani, Nada & Tachfouti, Nabil & Mernissi, Fatima & Fakir, Samira. (2023). Depression, Anxiety, and Quality of Life among Patients with Psoriasis: Prevalence, and Associated Factors. OALib. 10. 1-14. 10.4236/oalib.1109989.

Naldi, L., (2016). Psoriasis and smoking: Links and risks, Psoriasis: Targets and Therapy. Dove Medical Press Ltd, pp. 65-71. National Psoriasis Foundation. (2011). Mental health issue brief.

Nayak, P., Girisha, B., & Noronha, T. (2018). Correlation between disease severity, family income, and quality of life in psoriasis: A study from South India. Indian Dermatology Online Journal, 9(3), 165. https://doi.org/10.4103/idoj.idoj_250_17.

Parisi, R., Iskandar, I. Y. K., Kontopantelis, E., Augustin, M., Griffiths, C. E. M., Ashcroft, D. M., & Global Psoriasis Atlas (2020). National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ (Clinical research ed.), 369, m1590. https://doi.org/10.1136/bmj.m1590.

Petito, A., Piazzoli, A., Altamura, M., Bellomo, A., Bernardini, F., Scarponi, L., & Porcelli, P. (2020). Psychosomatic Syndromes And Symptom Severity In Chronic Psoriasis. Clinical Neuropsychiatry, 17(4).

Pollo, C.F., Miot, H.A., Matos, T.D.S.,.et al. (2021) Prevalence and factors associated with depression and anxiety in patients with psoriasis. J Clin Nurs.;30(3-4):572-580. doi:10.1111/jocn.15577.

Rendon, A., Schakel, K. (2019). Psoriasis pathogenesis and treatment. Int J Mol Sci.20:1-28.

Rigas, H.M., Bucur, S., Ciurduc, D.M., Nita, I.E., Constantin, M.M. (2019). Psychological Stress and Depression in Psoriasis Patients - a Dermatologist's Perspective. Maedica (Bucur). Sep;14(3):287-291. doi: 10.26574/maedica.2019.14.3.287. PMID: 31798747; PMCID: PMC6861725.

Sahi, F.M., Masood, A., Danawar, N.A., Mekaiel, A., Malik, B.H. (2020). Association Between Psoriasis and Depression: A Traditional Review. Cureus. Aug 13;12(8):e9708. doi: 10.7759/cureus.9708. PMID: 32944430; PMCID: PMC7489316.

Sallemi, R. & Bouhamed, Mariem & Masmoudi, R. & Feki, Ines & Masmoudi, Jawaher. (2021). Anxiety and depressive symptoms in patients with psoriasis. European Psychiatry. 64. S183-S184. 10.1192/j.eurpsy.2021.485.

Sarkar, R., Chugh, S., & Bansal, S. (2016). General measures and quality of life issues in psoriasis. Indian Dermatology Online Journal, 7(6), 481.

Styla, R., & Kowalski, J. (2020). Psychometric properties of the General Functioning Questionnaire (GFQ-58) used for screening for symptoms of psychopathology and overall level of functioning. Psychiatria Polska, 54(1), 83–100. https://doi.org/10.12740/PP/99564.

Susanti, R., Sakundarno Adi, M., Setyawan Susanto, H., Sutiningsih, D., Epidemiologi dan Penyakit Tropik, B., & Kesehatan Masyarakat, F. (2020). Gambaran Kualitas Hidup Penderita Psoriasi di Komunitas PSOBAT Jawa Tengah. 8(3). http://ejournal3.undip.ac.id/index.php/jkm.

Sondermann, W., Schreiber, A., Körber, A., Fiege, O., Scherbaum, N., Benson, S., & Schedlowski, M. (2020). Psychosocial burden and body mass index are associated with dermatology-related quality of life in psoriasis patients. European Journal of Dermatology, 30(2), 140-147.

Tohid, H., Aleem, D., Jackson, C. (2016). Major Depression and Psoriasis: A Psychodermatological Phenomenon. Skin Pharmacol Physiol. 29(4): 220- 30.

Voitsidis, P., Gliatas, I., Bairachtari, V., Papadopoulou, K., Papageorgiou, G., Parlapani, E., Syngelakis, M., Holeva, V., & Diakogiannis, I. (2020). Insomnia in a Greek population. Psychiatry Research, 289(April), 113076. https://doi.org/10.1016/j.psychres.2020.11307.

WHO. (2016). Michalek IM, Loring B, John SM. Global report on psoriasis. Geneva, Switzerland: World Health Organization; 2016.dults: a randomized trial. HIV medicine, 19(6), 411-419.

Downloads

Published

2026-05-06

How to Cite

Andray Hadi Texanto, Septiawan, D., Rohmaningtyas HS, & Wijaya Kusuma. (2026). Hubungan Psikopatologi dengan Kualitas Hidup pada Pasien Psoriasis. Bima Nursing Journal, 7(2), 137–148. https://doi.org/10.32807/bnj.v7i2.1895

Issue

Section

Articles

Citation Check